Alzheimer’s drug shows promise in human trials

An experimental drug shattered and removed toxic plaques in the brains of patients with early-stage Alzheimer’s disease, researchers said Thursday. Given to patients once a month for a year, infusions of the drug aducanumab cleared the brain of the deposits, which experts believe play a crucial role in disrupting cellular processes and blocking communication among nerve cells.

Source:: CNN Health